Together, it is clear that some CTCs may experience phenotypic changes during tumor evolution and that the expression of EpCAM may be transient, so EpCAM expression based methods may potentially miss a substantial subset of CTCs [57, 58]. This evidence concerns the gene EPCAM and neoplasm.